Press release
Peptide API Market Forecast 2034: Expansion of Biopharmaceutical R&D and Demand for Targeted Therapies Propel Market Growth | Transparency Market Research, Inc
Peptide API Market
Download now to explore primary insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86389
Market Overview: Peptide APIs, comprised of short chains of amino acids, play a crucial role in modern medicine, particularly in managing metabolic, cardiovascular, and oncological disorders. These biologically active compounds function as hormones, enzymes, and signaling molecules. Peptide therapeutics such as insulin, liraglutide, and semaglutide have proven efficacy in improving glycemic control and promoting weight loss, fueling their demand in clinical practice.
With significant strides in peptide production techniques and the evolution of targeted drug delivery systems, the peptide API industry is gaining attention from pharmaceutical giants, biotech firms, and contract manufacturers across the globe.
Market Drivers & Trends
A primary market driver is the global rise in chronic disease prevalence, including cardiovascular diseases, type 2 diabetes, and obesity. According to global health statistics, approximately 523 million people suffered from some form of cardiovascular disease in 2020, and chronic conditions are projected to cost the world US$ 47 trillion by 2030.
Another significant growth lever is the advancement in peptide synthesis technologies, such as Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and recombinant DNA techniques. These methods enable high-throughput, cost-effective, and scalable production of complex peptides, including long-chain variants.
Latest Market Trends
• GLP-1 receptor agonists are dominating the peptide API landscape owing to their dual role in type 2 diabetes and weight management.
• Once-weekly injection formulations and oral delivery options are gaining rapid acceptance, improving patient compliance.
• Pharmaceutical giants are heavily investing in expanding infrastructure for injectable treatments, as seen in Novo Nordisk's US$ 4.1 Bn investment in North Carolina.
• Microwave-assisted synthesis and automated synthesizers are further streamlining peptide production, enhancing reproducibility and yield.
Key Players and Industry Leaders
The market landscape is highly competitive, with major pharmaceutical and biotech firms driving innovation and market expansion. Key players include:
• Eli Lilly and Company
• Sanofi
• Novo Nordisk
• AstraZeneca
• GlaxoSmithKline
• PegBio Co. Ltd.
• Amgen Inc.
• Pfizer Inc.
• Innovent Biologics
• Sun Pharmaceuticals
• Boehringer Ingelheim
• Biocon
• Wockhardt Ltd.
These companies are actively investing in R&D and clinical trials to enhance product portfolios and expand global reach.
Recent Developments
• In August 2024, Eli Lilly reported positive Phase 3 trial results for tirzepatide, showing significant improvements in heart failure outcomes.
• In July 2024, Novo Nordisk announced a massive US$ 4.1 billion expansion to ramp up production of injectable peptide therapeutics.
• In May 2024, Amgen revealed clinical success with AMG 890, a GLP-1 receptor agonist targeting obesity, intensifying competition in the metabolic disorder space.
Market New Opportunities and Challenges
Opportunities:
• Expansion of oral peptide drug delivery systems
• Rising geriatric population across Asia Pacific
• Increasing focus on personalized peptide therapeutics
• Potential for peptide-based cancer therapies
Challenges:
• Peptides' instability in gastrointestinal tract limits oral bioavailability
• High production cost of complex peptide APIs
• Navigating regulatory complexities for therapeutic approval
Buy this Premium Research Report to access critical market intelligence - https://www.transparencymarketresearch.com/checkout.php?rep_id=86389<ype=S
Future Outlook
Analysts anticipate robust market performance over the next decade. The synergy between technological innovation, clinical advancements, and growing chronic disease prevalence will ensure sustained growth. Moreover, regulatory bodies are accelerating approvals for peptide-based therapies, providing a favorable framework for new entrants and established players alike.
Market Segmentation
By Drug Class:
• GLP-1 Receptor Agonists
• Insulin
• Other Peptide Classes
By Product Type:
• GLP-1 Receptor Agonist Oral Formulations
• GLP-1 Receptor Agonist Injectables
• Insulin Injectables
• Other Peptides
By Route of Administration:
• Oral
• Parenteral
By Application:
• Type 2 Diabetes Mellitus
• Type 1 Diabetes
• Obesity
• Non-alcoholic Fatty Liver Disease (NAFLD)
• Others
Regional Insights
North America led the global market in 2023 due to its robust healthcare infrastructure, high R&D investments, and rising incidence of chronic illnesses. The U.S. remains at the forefront, backed by advanced manufacturing capabilities and strong clinical networks.
Europe is also witnessing steady growth, particularly in Germany, France, and the U.K., owing to favorable regulatory support and increased funding for biotech innovations.
Asia Pacific is projected to record the fastest CAGR during the forecast period. The rising geriatric population, increasing healthcare spending, and growing demand for GLP-1 and insulin therapies are fostering regional expansion, especially in China, India, and Japan.
Why Buy This Report?
• Gain a comprehensive understanding of the peptide API market dynamics
• Analyze emerging trends, market drivers, and opportunities
• Identify growth segments and investment hotspots
• Review detailed company profiles, financials, and recent developments
• Access in-depth regional and segment-wise analysis
• Leverage strategic insights for product development and market entry
• Stay updated on competitive benchmarking and regulatory shifts
Explore Latest Research Reports by Transparency Market Research:
Lung Cancer Diagnostics Market: https://www.transparencymarketresearch.com/lung-cancer-diagnostics-market.html
Metabolomics Market: https://www.transparencymarketresearch.com/metabolomics-market.html
Sexually Transmitted Diseases (STD) Diagnostics Market: https://www.transparencymarketresearch.com/sexually-transmitted-disease-diagnostic.html
Legionella Testing Market: https://www.transparencymarketresearch.com/legionella-testing-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide API Market Forecast 2034: Expansion of Biopharmaceutical R&D and Demand for Targeted Therapies Propel Market Growth | Transparency Market Research, Inc here
News-ID: 4106913 • Views: …
More Releases from Transparency Market Research
Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 …
The global silicon carbide (SiC) ceramics market continues to demonstrate strong growth potential, underpinned by accelerating demand from advanced industrial and electronic applications. Valued at US$ 1.8 Billion in 2024, the market is projected to reach US$ 3.1 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2025 to 2035. This steady expansion reflects the increasing importance of SiC ceramics as…
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising D …
The global Furfuryl Alcohol Market was valued at US$ 624.3 million in 2024 and is projected to reach US$ 1,341.2 million by 2035, expanding at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2035.
This growth is primarily driven by the rising demand for bio-based and sustainable chemicals, along with the steady expansion of the foundry and metal casting industry, particularly across emerging economies in Asia Pacific.
Gain a…
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by …
The global Air-Entraining Agents (AEAs) Market was valued at US$ 1.70 billion in 2024 and is projected to reach US$ 2.48 billion by 2035, expanding at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2035. This steady growth trajectory reflects the essential role AEAs play in modern concrete formulations, particularly in infrastructure projects that demand long-term durability, freeze-thaw resistance, and improved workability.
Despite being a mature segment within…
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn …
The global Application-to-Person (A2P) SMS market is entering a phase of steady and resilient expansion, driven by the growing need for secure, reliable, and real-time communication between enterprises and consumers. Valued at US$ 71.2 Bn in 2024, the market is projected to reach US$ 117.0 Bn by 2035, expanding at a CAGR of 4.2% from 2025 to 2035. Despite the rise of internet-based messaging platforms, A2P SMS continues to maintain…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
